Clinical Trial Update: To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by AstraZeneca evaluated the effect of AZD3199 on cardiac electrical activity in people with chronic obstructive pulmonary disease; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD3199

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease, Lung Disease | Phase 1 | Status: COMPLETED